Table 1.
Acute Inflammation | ||||
---|---|---|---|---|
Model | Receptor | Netrin-1 Expression | Outcome | Ref. |
Lung Inflammation | ||||
S. aureus pneumonia in mice | Unc5b | ⇓ | Netrin-1 expression is attenuated in S. aureus septicemia. | [20] |
LPS and ventilator induced lung injury in mice | Adora2b | ⇓ | Netrin-1 expression is attenuated by inflammation, and netrin-1 limits neutrophil influx into the lung. | [29] |
LPS induced lung injury in pigs | not defined | Intravenous and inhalative netrin-1 mitigated pulmonary inflammation and lung damage. | [30] | |
Mouse model with LIRI | Adora2b | ⇓ | Positive correlation between netrin-1 expression and Treg cell population. | [31] |
An ALI model was established by intratracheal instillation of LPS in C57BL/J mice | Adora2b | ⇓ | Receptor binding has the potential to enhance ENaC-dependent alveolar fluid clearance by supplementation of netrin-1. | [32] |
Hypobaric hypoxia-induced lung injury in mice | UNC5HB | ⇓ | Pretreatment of netrin-1 dampen ALI and inhibits neutrophil migration. | [33] |
Abdominal Inflammation | ||||
Colitis | ||||
DSS-induced colitis | Adora2b | ⇑ in colon | Netrin-1 is induced during acute colitis limits neutrophil influx into the colonic epithelium. | [34] |
Peritonitis | ||||
ZyA-induced peritonitis | Adora2b | ⇓ | Netrin-1 expression is reduced during peritonitis. Exogenous netrin-1 application attenuates inflammation. | [35] |
ZyA-induced peritonitis | Adora2b | Netrin-1 synergistically interacts with RvD2 in an anti-inflammatory and pro-resolving fashion. | [27] | |
Pancreatitis | ||||
L-arginine-induced acute pancreatitis | not defined | ⇓ | Netrin-1 administration reduced pancreas and lung injury. | [36] |
Acute Kidney Injury | ||||
Ischemia–reperfusion-induced AKI | not defined | ⇑ protein levels in renal tissue mRNA in renal tissue protein and mRNA levels in intestine |
Netrin-1 is induced in renal tissue following IR. Ntn1 administration attenuates renal failure and kidney inflammation. | [37] |
Ischemia–reperfusion-induced AKI | not defined | not defined | Netrin-1 overexpression attenuates renal failure by decreased apoptosis and increased tubular epithelium proliferation. | [38] |
Ischemia–reperfusion-induced AKI | Unc5b | ⇓ mRNA in renal tissue |
Netrin-1 overexpression attenuates renal failure and systemic inflammation. | [39] |
Ischemia–reperfusion-induced AKI | not defined | ⇑ renal tissue |
Netrin-1 attenuates renal failure and systemic inflammation. | [40] |
Ischemia–reperfusion-induced AKI | not defined | not defined | Netrin-1 attenuates renal failure and promotes M2 polarization through PPARγ. | [16] |
Hypoxia | ||||
In vivo hypoxia | Adora2b | ⇑ in lung and colon via HIF-1α | Netrin-1 attenuates systemic inflammation and neutrophil recruitment. | [13] |
Liver-Ischemia Reperfusion | ||||
Adora2b | ⇓ in liver | Netrin-1 attenuates neutrophil recruitment, local and systemic inflammation and promotes resolution and tissue regeneration. | [28] | |
Myocardial Infarct | ||||
Normothermic ischemia reperfusion Langendorff perfusion | DCC | not defined | Netrin-1 pre- and postconditioning decrease infarct size and attenuate myocardiocyte apoptosis through ERK1/2 and NO induction. | [41,42,43] |
Heterotopic cardiac transplant with 8 h of cold ischemia | ⇓ | Netrin-1 protects from reperfusion injury by limiting leukocyte influx, cardiomyocyte apoptosis, and M2 macrophage polarization through PPARg. | [44] | |
Chronic LAD coronary ligation | not defined | not defined | Intracardial application of netrin-1-transduced mesenchymal stem cells attenuated infarction size and prevented cardiac hypertrophic remodeling. | [45] |
Normothermic ischemia reperfusion Langendorff perfusion |
not defined | not defined | Netrin-1 preconditioning attenuates infarcts size by preventing superoxide and NADPH oxidase production, preventing mitochondrial dysfunction. | [46] |